OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors
Jianshu Dong, Waqar Pervaiz, Bilal Tayyab, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114564-114564
Closed Access | Times Cited: 23
Jianshu Dong, Waqar Pervaiz, Bilal Tayyab, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114564-114564
Closed Access | Times Cited: 23
Showing 23 citing articles:
Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 55
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 55
LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer
Muqing Li, Mingyu Liu, Wanting Han, et al.
Cancer Research (2023) Vol. 83, Iss. 10, pp. 1684-1698
Open Access | Times Cited: 34
Muqing Li, Mingyu Liu, Wanting Han, et al.
Cancer Research (2023) Vol. 83, Iss. 10, pp. 1684-1698
Open Access | Times Cited: 34
2-Aminobenzothiazoles in anticancer drug design and discovery
G. Huang, Tomasz Cierpicki, Jolanta Grembecka
Bioorganic Chemistry (2023) Vol. 135, pp. 106477-106477
Closed Access | Times Cited: 28
G. Huang, Tomasz Cierpicki, Jolanta Grembecka
Bioorganic Chemistry (2023) Vol. 135, pp. 106477-106477
Closed Access | Times Cited: 28
In vitro functional validation of anti-CD19 chimeric antigen receptor T cells expressing lysine-specific demethylase 1 short hairpin RNA for the treatment of diffuse large B cell lymphoma
Zhi Guo, Mingxin He, Ning Liu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Zhi Guo, Mingxin He, Ning Liu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Mechanistic insights into novel cyano-pyrimidine pendant chalcone derivatives as LSD1 inhibitors by docking, ADMET, MM/GBSA, and molecular dynamics simulation
Amisha Gupta, Darakhshan Parveen, Faizul Azam, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101937-101937
Open Access
Amisha Gupta, Darakhshan Parveen, Faizul Azam, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101937-101937
Open Access
Machine Learning-based Virtual Screening of Reversible Inhibitors of LSD1 and Binding Mechanisms Study
Shaohui Liu, Fanru Yuan, Mengguo Chen, et al.
Journal of Molecular Structure (2025), pp. 142233-142233
Closed Access
Shaohui Liu, Fanru Yuan, Mengguo Chen, et al.
Journal of Molecular Structure (2025), pp. 142233-142233
Closed Access
Discovery of novel tranylcypromine-based derivatives as LSD1 inhibitors for gastric cancer treatment
Qisheng Ma, Yifan Zhang, Chengyang Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115228-115228
Closed Access | Times Cited: 9
Qisheng Ma, Yifan Zhang, Chengyang Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115228-115228
Closed Access | Times Cited: 9
Research progress of LSD1-based dual-target agents for cancer therapy
Xiaojuan Yang
Bioorganic & Medicinal Chemistry (2024) Vol. 101, pp. 117651-117651
Closed Access | Times Cited: 2
Xiaojuan Yang
Bioorganic & Medicinal Chemistry (2024) Vol. 101, pp. 117651-117651
Closed Access | Times Cited: 2
Anticancer Drugs of Lysine Specific Histone Demethylase-1 (LSD1) Display Variable Inhibition on Nucleosome Substrates
Dulmi Senanayaka, Danyun Zeng, Emre Deniz, et al.
Biochemistry (2024) Vol. 63, Iss. 11, pp. 1369-1375
Closed Access | Times Cited: 2
Dulmi Senanayaka, Danyun Zeng, Emre Deniz, et al.
Biochemistry (2024) Vol. 63, Iss. 11, pp. 1369-1375
Closed Access | Times Cited: 2
Discovery of novel, potent, and orally bioavailable HDACs inhibitors with LSD1 inhibitory activity for the treatment of solid tumors
Ying‐Chao Duan, Tong Yu, Linfeng Jin, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115367-115367
Closed Access | Times Cited: 6
Ying‐Chao Duan, Tong Yu, Linfeng Jin, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115367-115367
Closed Access | Times Cited: 6
Increased demand for FAD synthesis in differentiated and stem pancreatic cancer cells is accomplished by modulating FLAD1 gene expression: the inhibitory effect of Chicago Sky Blue
Alessia De Nisco, Tiago M. A. Carvalho, Maria Tolomeo, et al.
FEBS Journal (2023) Vol. 290, Iss. 19, pp. 4679-4694
Open Access | Times Cited: 5
Alessia De Nisco, Tiago M. A. Carvalho, Maria Tolomeo, et al.
FEBS Journal (2023) Vol. 290, Iss. 19, pp. 4679-4694
Open Access | Times Cited: 5
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma
Cecilia Bandini, Elisabetta Mereu, Tina Paradžik, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Cecilia Bandini, Elisabetta Mereu, Tina Paradžik, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Inhibition of LSD1 via SP2509 attenuated the progression of rheumatoid arthritis
Ziliang Yu, Peipei Li, Dagong Gao, et al.
Immunologic Research (2024) Vol. 72, Iss. 4, pp. 797-810
Closed Access | Times Cited: 1
Ziliang Yu, Peipei Li, Dagong Gao, et al.
Immunologic Research (2024) Vol. 72, Iss. 4, pp. 797-810
Closed Access | Times Cited: 1
Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors
Zhehao Fan, Xiaofeng Liu, Ning Wang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 1
Zhehao Fan, Xiaofeng Liu, Ning Wang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access | Times Cited: 1
Epigenetic Inhibitors as Alzheimer’s Disease Therapeutic Agents
Yasunobu Yamashita, Yukihiro Itoh, Yuri Takada, et al.
Chemical and Pharmaceutical Bulletin (2024) Vol. 72, Iss. 7, pp. 630-637
Open Access | Times Cited: 1
Yasunobu Yamashita, Yukihiro Itoh, Yuri Takada, et al.
Chemical and Pharmaceutical Bulletin (2024) Vol. 72, Iss. 7, pp. 630-637
Open Access | Times Cited: 1
Synthesis, anticancer, and docking of new thiadiazolyl-triazole analogues hybridized with thiazolidinone/thiophene
Menier Al‐Anazi
Journal of Molecular Structure (2023) Vol. 1278, pp. 134864-134864
Closed Access | Times Cited: 2
Menier Al‐Anazi
Journal of Molecular Structure (2023) Vol. 1278, pp. 134864-134864
Closed Access | Times Cited: 2
Target Ligand Separation and Identification of Isoforsythiaside as a Histone Lysine-Specific Demethylase 1 Covalent Inhibitor Against Breast Cancer Metastasis
Mengzhen Gu, Xiaoqing Xu, Xiaoping Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19874-19888
Closed Access
Mengzhen Gu, Xiaoqing Xu, Xiaoping Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19874-19888
Closed Access
KDM1A epigenetically enhances RAD51 expression to suppress the STING-associated anti-tumor immunity in esophageal squamous cell carcinoma
Qingyuan Yang, Shiyin Wei, Cen Qiu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 12
Open Access
Qingyuan Yang, Shiyin Wei, Cen Qiu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 12
Open Access
Epigenetics of cisplatin resistance
Anne‐Marie Baird, Steven G. Gray
Elsevier eBooks (2023), pp. 577-611
Closed Access | Times Cited: 1
Anne‐Marie Baird, Steven G. Gray
Elsevier eBooks (2023), pp. 577-611
Closed Access | Times Cited: 1
Design, synthesis and antitumor activity evaluation of tetrasubstituted pyrimidine derivatives containing methyl phenyl sulfone group
Chao Gao, Fuqiang Yu, Lingling Chi, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 10, pp. 2138-2155
Closed Access | Times Cited: 1
Chao Gao, Fuqiang Yu, Lingling Chi, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 10, pp. 2138-2155
Closed Access | Times Cited: 1
Anti-Proliferative Effect of Potential LSD1/CoREST Inhibitors Based on Molecular Dynamics Model for Treatment of SH-SY5Y Neuroblastoma Cancer Cell Line
Hiba Zalloum, Waleed A. Zalloum, Tareq Hameduh, et al.
Asian Pacific Journal of Cancer Prevention (2022) Vol. 23, Iss. 10, pp. 3533-3540
Open Access | Times Cited: 1
Hiba Zalloum, Waleed A. Zalloum, Tareq Hameduh, et al.
Asian Pacific Journal of Cancer Prevention (2022) Vol. 23, Iss. 10, pp. 3533-3540
Open Access | Times Cited: 1
6-Heterocyclic Carboxylic Ester Derivatives of Gliotoxin Lead to LSD1 Inhibitors in Gastric Cancer Cells
Lihong Shan, Zhaoxiang Li, Huabin Chen, et al.
SSRN Electronic Journal (2022)
Closed Access
Lihong Shan, Zhaoxiang Li, Huabin Chen, et al.
SSRN Electronic Journal (2022)
Closed Access
6-Heterocyclic carboxylic ester derivatives of gliotoxin lead to LSD1 inhibitors in gastric cancer cells
Lihong Shan, Zhaoxiang Li, Huabin Chen, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106150-106150
Closed Access
Lihong Shan, Zhaoxiang Li, Huabin Chen, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106150-106150
Closed Access
